Apollo Hospitals Enterprise Limited has informed the Exchange that Board of Directors at its meeting held on May 20, 2026, recommended Final Dividend of Rs. 10 per equity share.
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty 100 and 3.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Apollo Hospitals reported strong FY26 results with consolidated revenue of Rs 252.3 billion (up 16% YoY) and net profit of Rs 20 billion (up 33% YoY). Consolidated EPS stood at Rs 135.04 vs Rs 100.56 prior year. The Board recommended a final dividend of Rs 10 per share (200% on Rs 5 face value), adding to the Rs 10 interim dividend already paid in February 2026. Key strategic actions include: merger of subsidiary Apollo Hospitals North Limited into the parent; Apollo Health and Lifestyle Limited combining with Cloudnine (Kids Clinic India) at enterprise value of Rs 15,500 million; and ongoing composite scheme for demerger of pharmacy distribution and digital health platform into Apollo Healthtech Limited. The company also fully acquired Apollo Health and Lifestyle Limited during the year.
Strong earnings growth and two-tier dividend payout signal healthy cash generation. The Cloudnine transaction and merger proposals are positive for long-term consolidation but create near-term uncertainty around subsidiary restructuring. Shareholders should note record date of August 14, 2026 for final dividend entitlement.